We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
(-3.6%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.93B |
| 2 |
Kenvue
KVUE
|
+$537M |
| 3 |
Humana
HUM
|
+$477M |
| 4 |
AbbVie
ABBV
|
+$441M |
| 5 |
Microsoft
MSFT
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
Apple
AAPL
|
+$565M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$467M |
| 4 |
McKesson
MCK
|
+$347M |
| 5 |
Intel
INTC
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Consumer Staples | 7.45% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Aaon
AAON
$8.27B
| $504K | ﹤0.01% |
8,856
-110,891
| -93% | -$7.05M |
|
1702
Rockwell Medical
RMTI
$27.6M
| $503K | ﹤0.01% |
24,190
+22,579
| +1,402% | +$686K |
|
1703
Allegiant Air
ALGT
$2.66B
| $501K | ﹤0.01% |
6,519
-94,269
| -94% | -$9.69M |
|
1704
Kratos Defense & Security Solutions
KTOS
$9.27B
| $499K | ﹤0.01% |
+33,249
| New | +$495K |
|
1705
FLEX LNG
FLNG
$1.65B
| $499K | ﹤0.01% |
16,558
-177,510
| -91% | -$5.48M |
|
1706
BrightView Holdings
BV
$1.33B
| $499K | ﹤0.01% |
64,396
-83,404
| -56% | -$666K |
|
1707
CALL
iShares MSCI Turkey ETF
TUR
$203M
| $497K | ﹤0.01% |
12,900
+12,600
| +4,200% | +$441K |
|
|
KALV
1708
DELISTED
KalVista Pharmaceuticals
KALV
| $496K | ﹤0.01% |
+51,524
| New | +$526K |
|
1709
McEwen Inc
MUX
$1.04B
| $489K | ﹤0.01% |
75,165
+60,550
| +414% | +$456K |
|
1710
CytomX Therapeutics
CTMX
$708M
| $487K | ﹤0.01% |
377,593
-296,908
| -44% | -$467K |
|
1711
American Public Education
APEI
$907M
| $485K | ﹤0.01% |
97,451
-94,766
| -49% | -$485K |
|
1712
IHS Holding
IHS
$2.77B
| $482K | ﹤0.01% |
86,906
-34,083
| -28% | -$253K |
|
|
PLYM
1713
DELISTED
Plymouth Industrial REIT
PLYM
| $482K | ﹤0.01% |
+22,993
| New | +$517K |
|
1714
RE/MAX Holdings
RMAX
$207M
| $481K | ﹤0.01% |
+37,157
| New | +$645K |
|
1715
Nextpower Inc
NXT
$15.7B
| $477K | ﹤0.01% |
11,883
-116,057
| -91% | -$4.7M |
|
|
PL.WS
1716
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
| $477K | ﹤0.01% |
183,344
-46,736
| -20% | -$21.6K |
|
1717
Aquestive Therapeutics
AQST
$468M
| $476K | ﹤0.01% |
310,809
+38,414
| +14% | +$66.1K |
|
1718
Banco Bradesco
BBD
$38.5B
| $472K | ﹤0.01% |
+165,459
| New | +$524K |
|
1719
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.2B
| $472K | ﹤0.01% |
+19,076
| New | +$515K |
|
1720
PUT
iShares US Transportation ETF
IYT
$2.32B
| $468K | ﹤0.01% |
8,000
-7,600
| -49% | -$475K |
|
1721
Nuvectis Pharma
NVCT
$616M
| $465K | ﹤0.01% |
36,085
-5,690
| -14% | -$82.4K |
|
1722
Adtran
ADTN
$769M
| $465K | ﹤0.01% |
+56,492
| New | +$502K |
|
|
DAO
1723
Youdao
DAO
$1.91B
| $464K | ﹤0.01% |
115,526
+59,282
| +105% | +$250K |
|
|
BIG
1724
DELISTED
Big Lots, Inc.
BIG
| $461K | ﹤0.01% |
90,275
+77,115
| +586% | +$587K |
|
1725
Vinci Compass Investments Ltd
VINP
$637M
| $461K | ﹤0.01% |
+45,189
| New | +$456K |
|
Similar funds
Marshall Wace's Q3 2023 Portfolio in Review
As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
- Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
- Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
- Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
- Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
- Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.